Company Overview and News

 
Closing Bell: Sensex sheds 306 pts, Nifty ends below 10,500 on weaker rupee

14m moneycontrol
Market Closing: Benchmark indices after yesterday's breather resumed selling pressure again, with the Sensex losing more than 300 points on weaker rupee and global weakness.

 
Market Live: Nifty extends losses, Sensex down 200 pts; HPCL, BPCL, IOC dip 4-9%

1h moneycontrol
Earnings: Archies has reported net profit of Rs 30.6 crore in the Q4FY18 against loss of Rs 1.6 crore in the same quarter last fiscal.

 
Market Live: Nifty extends losses, Sensex down 100 pts; Motherson dips, Bajaj Electricals gains

2h moneycontrol
Earnings Reaction: GVK Power share price rallied 10 percent after the company reported profit at Rs 23.1 crore in March quarter 2018 against loss of Rs 205.8 crore in March quarter 2017.

 
Market Update: PSU banks rally led by SBI, Andhra Bank; HPCL, BPCL fall 4%

2h moneycontrol
The market is trading on a negative note this Wednesday afternoon, with the Nifty down 21 points at 10,514 and the Sensex down 19 points at 34,631.

 
Market Live: Sensex, Nifty rangebound; rupee hits fresh 16-month low

3h moneycontrol
IMD on Monsoon: India Meteorological Department said it did not see possibility of El Nino this year.

 
Tata Motors kills the switch on Indigo, Indica production

4h moneycontrol
Tata Motors is phasing out the Indica and Indigo as consumers have moved on to trendier models offered in the market.

 
Market Live: Sensex under pressure; SBI lifts PSU Bank over 3%, metals lose shine

5h moneycontrol
Market Update: The market remained mildly under pressure, with the Nifty falling below the 10,500 levels following weakness in global stocks.

 
Market Update: CNX PSU banks outperforms as SBI jumps 5%; UltraTech hits new 52-week low

5h moneycontrol
The market is trading on a negative note on Wednesday morning, with the Nifty down 37 points at 10,499 and the Sensex down 100 points at 34,550.

 
Tata Motors Q4 FY18 Results today: JLR sales slowdown seen impacting profit

6h livemint
Mumbai: Tata Motors Ltd, India’s largest automaker by sales revenue and second largest by net profit, will report its March quarter (Q4 FY18) results on Wednesday.

 
Tata Motors and Micron Technology rise; Toll Brothers slumps

13h nzherald.co.nz
The department store said Chairman and CEO Marvin Ellison is leaving to become CEO of Lowe's.

 
China cuts duty on automobile imports to 15 per cent

15h thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com

 
Jet Air, Tata Motors, IFCI results on Wednesday

17h thehindubusinessline
About 75 companies including Aries Agro, Atlas Cycles, Bajaj Electricals, CESC, Cosmo Films, Dhanlaxmi Bank, eClerx, Entertainment Network, Eros, Finolex, GE T&D, Godrej Industries, Grasim, GVK Power, HG Infra, IFCI, Indraprastha Gas, Jet Airways, Jain Irrigation, KPIT Tech, L&T Infotech, MEP Infra, Natco Pharma, Omaxe, Ramco Cements, Repco Home, Shipping Corp, SML Isuzu, Suntech Realty, Tata Motors and Vidhi Specialty will declare their quarter and full-year results on Wednesday.

 
Tata Motors: This Indian Automobiles Player Is Trading At A Heavy Discount

19h seekingalpha
Tata Motors is an India-based manufacturer of commercial and consumer vehicles having a distribution network across 5 continents and over a 100 countries.

 
US stocks edge higher as technology companies, banks rise

19h nzherald.co.nz
NEW YORK (AP) — Technology companies and banks are rising Tuesday morning as U.S. stocks head higher for the second day in a row. Automakers are climbing after China said it will reduce auto import duties, another sign the two powers are resolving some of their differences on trade. Chipmaker Micron Technology is surging after it said it will buy back $10 billion in stock.

 
Markets Right Now: US stocks open broadly higher

20h nzherald.co.nz
Stocks are opening broadly higher on Wall Street as the U.S. and China make more progress on defusing their trade tensions.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 876568502